The MYCN oncogene is a direct target of miR-34a

Oncogene

Volumn 27, Issue 39, 2008, Pages 5204-5213

  Wei, J S ^a   Song, Y K ^a   Durinck, S ^a   Chen, Q R ^a,b   Cheuk, A T C ^a   Tsang, P ^a   Zhang, Q ^a   Thiele, C J ^a   Slack, A ^c   Shohet, J ^c   Khan, J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

1p36 LOH; MicroRNA; miR 34a; MYCN; Neuroblastoma; Translation regulation

Indexed keywords

MICRORNA; MICRORNA 34A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL FUNCTION; CELL GROWTH; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; DNA SYNTHESIS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MYCN ONCOGENE; NEUROBLASTOMA CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; DNA PRIMERS; HUMANS; LOSS OF HETEROZYGOSITY; MICRORNAS; MUTAGENESIS, SITE-DIRECTED; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 51349157982     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.154     Document Type: Article

References (66)

1. Abel F, Sjoberg RM, Krona C, Nilsson S, Martinsson T. (2004). Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors. Int J Oncol 25: 1297-1302.
2. Ambros V. (2004). The functions of animal microRNAs. Nature 431: 350-355.
3. Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D et al. (2005). Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353: 2243-2253.
4. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ. (1991). Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2: 245-255.
5. Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D et al. (2007). CHD5 is a tumor suppressor at human 1p36. Cell 128: 459-475.
6. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. (2005). Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11: 1119-1128.
7. Bartel B, Bartel DP. (2003). MicroRNAs: at the root of plant development? Plant Physiol 132: 709-717.
8. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Bieche I, Khodja A, Lidereau R. (1998). Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma. Oncol Rep 5: 267-272.
10. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN et al. (1993). Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 13: 5216-5224.
11. Brodeur GM. (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
12. Brodeur GM, Sekhon G, Goldstein MN. (1977). Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256-2263.
13. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529.
14. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
15. Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL et al. (2004). cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics 5: 70.
16. Cheung TH, Lo KW, Yim SF, Poon CS, Cheung AY, Chung TK et al. (2005). Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer. Gynecol Oncol 96: 510-515.
17. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949.
18. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103: 7024-7029.
19. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. (2003). DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4: P3.
20. Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A et al. (2005). BioMart and bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21: 3439-3440.
21. Eggert A, Grotzer MA, Zuzak TJ, Ikegaki N, Zhao H, Brodeur GM. (2002). Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system. Eur J Cancer 38: 92-98.
22. Ejeskar K, Krona C, Caren H, Zaibak F, Li L, Martinsson T et al. (2005). Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 5: 161.
23. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
24. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE et al. (1989). Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 86: 3753-3757.
25. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO et al. (1999). Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18: 4948-4957.
26. Hashimoto N, Ichikawa D, Arakawa Y, Date K, Ueda S, Nakagawa Y et al. (1995). Frequent deletions of material from chromosome arm 1p in oligodendroglial tumors revealed by double-target fluorescence in situ hybridization and microsatellite analysis. Genes Chromosomes Cancer 14: 295-300.
27. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005). The role of micro RNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
28. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
29. Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B et al. (2006). Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res 12: 131-138.
30. Hogarty MD, Liu X, Guo C, Thompson PM, Weiss MJ, White PS et al. (2000). Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 35: 512-515.
31. Hosoi G, Hara J, Okamura T, Osugi Y, Ishihara S, Fukuzawa M et al. (1994). Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73: 3087-3093.
32. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
33. Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH. (2006). MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem Biophys Res Commun 351: 192-197.
34. Kohl NE, Gee CE, Alt FW. (1984). Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 226: 1335-1337.
35. Kong XT, Valentine VA, Rowe ST, ValentineMB, Ragsdale ST, Jones BG et al. (1999). Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines. Neoplasia 1: 80-89.
36. Lahti JM, Valentine M, Xiang J, Jones B, Amann J, Grenet J et al. (1994). Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat Genet 7: 370-375.
37. Li C, Wong WH. (2001). Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36.
38. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
39. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
40. Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM et al. (2001). Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol 36: 32-36.
41. Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA et al. (1997). Human Kruppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene? Eur J Cancer 33: 1991-1996.
42. Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS et al. (2000). Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol 18: 1888-1899.
43. Mathysen D, Van Roy N, Van Hul W, Laureys G, Ambros P, Speleman F et al. (2004). Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines. Eur J Cancer 40: 1255-1261.
44. Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G et al. (1998). Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 92: 3405-3409.
45. Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D et al. (2005). High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43: 390-403.
46. Nara K, Kusafuka T, Yoneda A, Oue T, Sangkhathat S, Fukuzawa M. (2007). Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. Int J Oncol 30: 1189-1196.
47. Nesbit CE, Tersak JM, Prochownik EV. (1999). MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016.
48. Ozaki T, Hosoda M, Miyazaki K, Hayashi S, Watanabe K, Nakagawa T et al. (2005). Functional implication of p73 protein stability in neuronal cell survival and death. Cancer Lett 228: 29-35.
49. Poetsch M, Woenckhaus C, Dittberner T, Pambor M, Lorenz G, Herrmann FH. (1998). An increased frequency of numerical chromosomal abnormalities and 1p36 deletions in isolated cells from paraffin sections of malignant melanomas by means of interphase cytogenetics. Cancer Genet Cytogenet 104: 146-152.
50. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
51. Schwab M, Bishop JM. (1988). Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. Proc Natl Acad Sci USA 85: 9585-9589.
52. Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A et al. (2005). The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc Natl Acad Sci USA 102: 731-736.
53. Strieder V, Lutz W. (2003). E2F proteins regulate MYCN expression in neuroblastomas. J Biol Chem 278: 2983-2989.
54. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
55. Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM. (2003). CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 22: 1002-1011.
56. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg R. (2005). Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 65: 3136-3145.
57. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM et al. (1993). Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53: 5269-5273.
58. Wei JS, Khan J. (2002). Purification of total RNA from mammalian cells and tissues. In: Bowtell D, Sambrook J (eds). DNA Microarrays: A Molecular Cloning Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, pp 110-119.
59. Wei JS, Whiteford CC, Cenacchi N, Son CG, Khan J. (2005). BBC3 mediates fenretinide-induced cell death in neuroblastoma. Oncogene 24: 7976-7983.
60. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. (1997). Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16: 2985-2995.
61. Welch C, Chen Y, Stallings RL. (2007). MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022.
62. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M et al. (1995). A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92: 5520-5524.
63. White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M et al. (2005). Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24: 2684-2694.
64. Woo CW, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ. (2007). Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Pediatr Blood Cancer 50: 208-212.
65. Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA et al. (1986). Differential expression of myc family genes during murine development. Nature 319: 780-783.
66. Zindy F, Knoepfler PS, Xie S, Sherr CJ, Eisenman RN, Roussel MF. (2006). N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development. Proc Natl Acad Sci USA 103: 11579-11583.